GlassScriptPhysician profile
Neeraj Jain
NPI 1316028657
$6,937.79
in general payments reported to CMS, 2019-2025
26 companies · $1,503 in 2025
The $1,503 reported for 2025 was more than what 76% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $162 · 2021: $2,790 · 2022: $987 · 2023: $324 · 2024: $734 · 2025: $1,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,094 · Travel and Lodging: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,093.84 |
| Travel and Lodging | $467.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,621.37 | 2021-2025 | Eterna, Proclaim, Ionicrf |
| Electronic Waveform Lab, INC. | $1,577.77 | 2021-2022 | |
| Relievant Medsystems, INC. | $964.40 | 2020-2023 | Intracept |
| Surgentec | $467.15 | 2025 | Ion |
| Boston Scientific Corporation | $367.15 | 2019-2025 | General - Therapies, Intracept, Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $319.06 | 2024-2025 | Sprint Pns System |
| Medtronic, INC. | $264.41 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Abiomed | $233.56 | 2019 | |
| Biotronik Nro, INC. | $186.16 | 2024 | Prospera |
| Painteq LLC | $182.27 | 2021-2024 | Painteq |
| Recor Medical INC | $148.44 | 2025 | Paradise Ultrasound Renal Denervation System |
| Collegium Pharmaceutical, INC. | $132.69 | 2020-2024 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.63 | 2019-2020 | |
| Terumo Bct, INC. | $77.29 | 2021-2022 | |
| Nalu Medical, INC. | $52.72 | 2021-2023 | Nalu Neurostimulation System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $34.23 | 2019 | |
| Averitas Pharma INC. | $33.92 | 2025 | Qutenza |
| Currax Pharmaceuticals LLC | $31.67 | 2020 | |
| Depuy Synthes Sales INC. | $22.40 | 2020 | |
| Medtronic USA, INC. | $17.72 | 2019 | |
| Vertos Medical, INC. | $15.81 | 2023 | Mild Device Kit |
| Daiichi Sankyo INC. | $15.64 | 2019 | |
| Abbvie INC. | $13.69 | 2022 | |
| Horizon Therapeutics Plc | $13.56 | 2020 | |
| Si-Bone, INC. | $12.26 | 2019 | |
| Lilly USA, LLC | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeraj Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.